Targeted therapy of anaplastic thyroid cancer
Introduction. Anaplastic thyroid cancer (ATC) is a very rare malignant tumor of the thyroid comprising 1–2 % of all thyroid cancers. In this pathology, response rate for standard systemic therapy is less than 15 %, and long-term results remain unsatisfactory. Additionally, there are no data conclusi...
Saved in:
| Main Authors: | P. A. Nikiforovich, A. P. Polyakov, I. V. Sleptsov, N. S. Boyko, Yu. A. Gronskaya, N. I. Timofeeva, R. A. Chernikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-03-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/841 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anaplastic thyroid cancer: current state of the problem
by: P. A. Nikiforovich, et al.
Published: (2025-05-01) -
Systemic therapy for anaplastic thyroid cancer: a literature review
by: E. S. Dzhelialov, et al.
Published: (2025-01-01) -
Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
by: A. L. Pylev, et al.
Published: (2020-04-01) -
TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
by: P. A. Nikiforovich, et al.
Published: (2020-10-01) -
Visceral Perforation Complicating BRAF/MEK Targeted Therapy of Papillary Thyroid Carcinoma with Anaplastic Areas
by: Simon L. Barry, et al.
Published: (2024-12-01)